Century Therapeutics
Price & Volume
Stats
See moreOpen | $2.44 |
Previous Close | $2.37 |
Day Range | $2.42-$2.61 |
52W Range | $0.43-$3.04 |
Market Cap | $425.9M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $109.1M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $13.4M |
Diluted EPS | -$0.15 |
News
See moreYahoo Finance • 2 months ago
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Yahoo Finance • 2 months ago
Cheap high flyer healthcare stocks - high momentum and low valuation
Yahoo Finance • 4 months ago
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
Yahoo Finance • 5 months ago
Century Therapeutics GAAP EPS of -$0.40 misses by $0.06, revenue of $0M
About
CEO | Dr. Brent Pfeiffenberger M.B.A., Pharm.D. |
Address | 25 North 38th Street, Philadelphia, PA, United States, 19104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 78 |
